Prior Percutaneous Coronary Interventions May Be Associated With Increased Mortality After Coronary Bypass Grafting: A Meta-Analysis.


Journal

Seminars in thoracic and cardiovascular surgery
ISSN: 1532-9488
Titre abrégé: Semin Thorac Cardiovasc Surg
Pays: United States
ID NLM: 8917640

Informations de publication

Date de publication:
2020
Historique:
received: 17 09 2019
accepted: 17 09 2019
pubmed: 27 9 2019
medline: 1 7 2020
entrez: 27 9 2019
Statut: ppublish

Résumé

There is conflicting evidence for adverse outcomes after coronary artery bypass surgery (CABG) with prior percutaneous intervention (PCI). A literature search was performed from 1998 to 2017 and articles with primary or secondary outcomes of survival, major adverse cardiovascular events (MACE), and myocardial infarction in CABG patients with prior PCI were included. Forest plots were generated from odds ratios for survival, MACE, and myocardial infarction for unmatched and propensity-matched data. Heterogeneity between studies was assessed for all outcomes using I

Identifiants

pubmed: 31557513
pii: S1043-0679(19)30278-3
doi: 10.1053/j.semtcvs.2019.09.009
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-74

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Suvitesh Luthra (S)

Southampton University Hospitals, Southampton, United Kingdom. Electronic address: drsl00@gmail.com.

Miguel M Leiva-Juárez (MM)

Department of Surgery, Brookdale University Hospital and Medical Center, Brooklyn, New York.

Brian Shine (B)

University of Oxford, Oxford, United Kingdom.

Nawwar Al-Attar (N)

Golden Jubilee National Hospital, Glasgow, United Kingdom.

Sunil Ohri (S)

Southampton University Hospitals, Southampton, United Kingdom.

David P Taggart (DP)

University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH